Sixfold Bioscience
PrivateLast Round
Grant
Mar 1, 2023
Total Funding Raised
$11.93M
Momentum Score
25 /100
Company Overview
Sixfold Bioscience is a preclinical biotechnology company, founded in 2017, developing a programmable drug delivery system for RNA therapeutics. The company's proprietary Mergo® platform utilizes computation, advanced chemistry, and machine learning to design systems for delivering RNA molecules, such as siRNA and mRNA, to specific cells and tissues beyond the liver. This technology aims to overcome a key challenge in the field, potentially unlocking the therapeutic potential of RNA-based medicines for a wide range of diseases, with an initial focus on oncology. The company is venture-backed, having raised $10.5 million in seed funding from investors including Y Combinator and Cantos Ventures.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sixfold Bioscience Comps
Public and private peers based on sector, stage, and business model.
Sixfold Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 1, 2023 | ||||
| Seed | Dec 2, 2021 | ||||
| Grant | Aug 4, 2020 | ||||
| Accelerator | Mar 16, 2018 |
Sixfold Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Pi Campus | Seed |
| Cantos Ventures | Seed |
| Y Combinator | Seed, Accelerator |
Sixfold Bioscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sixfold Bioscience's valuation, stock price, and market status.
